PREGABALIN
Generic: PREGABALIN
Dr.Reddys Laboratories IncManufacturer
ORALRoute
PREGABALINActive Substance
2019-07-19Original Approval
PREGABALIN is FDA application ANDA209664, sponsored by DR REDDYS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2021-03-15
PREGABALIN CAPSULES 300MG 90 ; NDC 43598-298-90; RX; CAPSULESCGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class III2024-05-16
Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJPresence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packagi
Class II2021-10-22
Pregabalin Capsules, 50 mg, 100 count bottle, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJFailed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution an
Top Reported Reactions
1
DRUG INEFFECTIVE
7,620 reports
2
OFF LABEL USE
5,769 reports
3
FATIGUE
5,726 reports
4
PAIN
5,106 reports
5
NAUSEA
5,076 reports
6
TOXICITY TO VARIOUS AGENTS
4,777 reports
7
HEADACHE
4,464 reports
8
DYSPNOEA
4,260 reports
9
DIZZINESS
4,246 reports
10
DIARRHOEA
3,883 reports